News

Sarepta Therapeutics crisis is huge blow to Duchenne families, company
Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular ...
NBC4 WCMH-TV on MSN1d
Sarepta Therapeutics lays off 500 employees amid FDA investigation, including 80 in Columbus
Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location.
Hoodline22h
Sarepta Therapeutics Announces Layoff of 493 Employees, Including 80 in Ohio, Amid FDA Scrutiny and Stock Decline
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting
The drastic cost-cutting move follows the deaths of two teenagers that forced the company to restrict usage of its gene therapy for Duchenne muscular dystrophy.
Sarepta Therapeutics laying off 80 employees in Ohio
Sarepta Therapeutics to lay off 493 workers, including 80 in Ohio, amid FDA probe, stock plunge, and concerns over Duchenne ...
Becker's Hospital Review5y
Sarepta under pressure as competitor files with FDA for muscular ...
Sarepta has not yet announced a plan to address the FDA’s concerns about its drug, but said it plans to meet with the FDA before the end of the year, according to STAT. Sarepta’s stock price ...
Benzinga.com1mon
STAT+: After second Sarepta death, Duchenne muscular ... - Benzinga
Hearing that a second boy with Duchenne had died from liver failure after receiving Elevidys was a shock, said Kameron Lawson, speaking to STAT on Sunday night from their home in Stockton, Calif.
Reuters2y
Sarepta drops as report says FDA almost rejected under-review gene ...
Sarepta Therapeutics Inc's shares fell more than 6% on Thursday as Stat News reported that the U.S. health regulator's staff were inclined to reject the company's gene therapy which is currently ...